Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


WIRTH PETER Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 18,903 shares @ $26.45, valued at $500k
06/02/2023 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 4,000 shares @ $0
Granted 6,000 options to buy @ $3.7, valued at $22.2k
12/12/2022 4/A WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Bought 4,000 shares @ $71.36, valued at $285.4k
12/09/2022 4 WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Sold 3,852 shares @ $35.37, valued at $136.2k
Sold 4,000 shares @ $35.33, valued at $141.3k
10/14/2022 4 WIRTH PETER (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.
Txns: Unknown transaction of 127,665 shares @ $0
Unknown transaction of 7,250 shares @ $0
Disposed/sold 14,026 options to buy @ $5.05, valued at $70.8k
Disposed/sold 28,053 options to buy @ $5.43, valued at $152.3k
Disposed/sold 17,533 options to buy @ $20, valued at $350.7k
Disposed/sold 8,375 options to buy @ $25.35, valued at $212.3k
Disposed/sold 6,750 options to buy @ $6.12, valued at $41.3k
09/19/2022 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 8,000 shares @ $0
Granted 12,000 options to buy @ $7.349, valued at $88.2k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2022 4 WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 7,763 shares @ $0
12/08/2021 4 WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Bought 4,000 shares @ $71.36, valued at $285.4k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2021 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $6.3, valued at $110.3k
01/20/2021 4 WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 3,852 shares @ $0
01/19/2021 3/A WIRTH PETER (Director) has filed a Form 3/A on Zai Lab Ltd
01/19/2021 3/A WIRTH PETER (Director) has filed a Form 3/A on Zai Lab Ltd
01/04/2021 3 WIRTH PETER (Director) has filed a Form 3 on Zai Lab Ltd
06/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/18/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
06/11/2020 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 17,500 options to buy @ $9.17, valued at $160.5k
06/12/2019 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $5.6, valued at $61.6k
06/15/2018 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Granted 11,000 options to buy @ $12.95, valued at $142.5k
01/30/2017 4 WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.
01/30/2017 3 WIRTH PETER (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc.
06/23/2015 4 WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Disposed/sold 7,500 options to buy @ $40.32, valued at $302.4k
Disposed/sold 15,000 options to buy @ $40.74, valued at $611.1k
Disposed/sold 7,500 options to buy @ $80.35, valued at $602.6k
06/05/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
06/10/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/29/2012 4 WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 15,000 options to buy @ $40.74, valued at $611.1k
06/29/2012 3 WIRTH PETER (Director) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP
04/06/2011 4 WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP
Txns: Unknown transaction of 15,660 shares @ $74, valued at $1.2M
Disposed/sold 29,250 shares @ $74, valued at $2.2M
Unknown transaction of 148 shares @ $74, valued at $11k
Exercised 14,250 restricted stock units @ $0
Exercised 15,000 restricted stock units @ $0
Disposed/sold 42,750 options to buy @ $51.52, valued at $2.2M
Disposed/sold 42,750 options to buy @ $58.66, valued at $2.5M
Disposed/sold 45,000 options to buy @ $68.48, valued at $3.1M
Disposed/sold 45,000 options to buy @ $62.16, valued at $2.8M
Disposed/sold 69,000 options to buy @ $58.5, valued at $4M
Disposed/sold 69,000 options to buy @ $62.98, valued at $4.3M
06/18/2010 4 WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP
Txns: Granted 42,750 options to buy @ $51.52, valued at $2.2M
05/26/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
05/19/2010 4 WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP
Txns: Sold 48,216 shares @ $50.51, valued at $2.4M
Exercised 48,216 options to buy @ $26.5, valued at $1.3M
05/26/2009 4 WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy